A Novel Derivative of Doxorubicin, AD198, Inhibits Canine Transitional Cell Carcinoma and Osteosarcoma Cells In Vitro

    September 2015 in “ Drug Design Development and Therapy ”
    Maria Cekanova, Kusum Rathore

    We don't know much about this study yet.

    We're maintaining the world's largest resposity of hair loss research. You can help out the community by sending a PDF of this study here . Not sure how to get a study's PDF? You can email the authors of the study.
    Discuss this study in the Community →